Donna Ockenden, a seasoned midwife, has been appointed to lead an independent review into maternity services at University Hospitals Sussex NHS Trust. This move comes after Health Secretary Wes Streeting announced an investigation into the trust's maternity care last year. Ockenden's appointment is seen as a significant step towards addressing concerns over patient safety and care quality in the region.
What Happened
The investigation was sparked by concerns over the trust's handling of maternity cases, including allegations of poor care and inadequate staffing. Streeting met with families who had experienced bereavement and harm, and agreed that the inquiry would begin as soon as possible. The NHS trust has committed to working "openly and transparently" with the review team and families.
Why It Matters
The inquiry is not only significant for the families affected but also for the wider healthcare system. Maternity services are a critical aspect of healthcare, and ensuring that they are safe and effective is essential. The review will examine the trust's policies, procedures, and practices to identify areas for improvement.
What Experts Say
"It's essential that we get this review up and running, and that it has the confidence of families and the public." — Wes Streeting, Health Secretary
Key Facts
- Who: Donna Ockenden, senior midwife
- What: Leading an independent review into maternity services at University Hospitals Sussex NHS Trust
- Where: University Hospitals Sussex NHS Trust
- Impact: The review aims to improve patient safety and care quality in maternity services
Background
Ockenden previously led a review into failings at Shrewsbury and Telford Hospital NHS Trust and is leading reviews of maternity services in Nottingham and Leeds. Her expertise and experience make her an ideal candidate to lead this inquiry.
What Comes Next
The inquiry will examine the trust's policies, procedures, and practices to identify areas for improvement. The review team will work closely with families and the NHS trust to ensure that the recommendations are implemented effectively. The outcome of the inquiry will have significant implications for the future of maternity services in Sussex and beyond.
In other healthcare news, a recent article explored common foot problems, from bunions to verrucas, and why diseases affecting our blood vessels or nerves often show up in the feet. Meanwhile, the FDA will convene an outside panel of advisers to discuss whether to allow compounding pharmacies to manufacture certain peptides. A new biotech startup, Beeline Medicine, has also been launched to develop treatments for inflammatory and immune disorders.